Global Inhaled Corticosteroid Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Asthma is a disease of the entire respiratory tract, including large, intermediate and small airways. Asthma led to inflammation and obstruction of respiratory tract. Patients have various treatment options for asthma, particularly for young and elderly patients. Hence this has led to significant interest on the part of the inhaler device which is easy to use. Inhaled corticosteroid is the most commonly used tool for the treatment of asthma. As with increasing pollution and increasing incidences of asthma, many companies are engaged in the development of new inhaler corticosteroid devices.
The global Inhaled Corticosteroid market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Inhaled Corticosteroid Industry Forecast” looks at past sales and reviews total world Inhaled Corticosteroid sales in 2023, providing a comprehensive analysis by region and market sector of projected Inhaled Corticosteroid sales for 2024 through 2030. With Inhaled Corticosteroid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inhaled Corticosteroid industry.
This Insight Report provides a comprehensive analysis of the global Inhaled Corticosteroid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Inhaled Corticosteroid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Inhaled Corticosteroid market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inhaled Corticosteroid and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inhaled Corticosteroid.
In terms of market value, North America will dominate the inhaler corticosteroid device market during the forecast period. Increasing incidences of life-threatening illness such as chronic obstructive pulmonary disease, asthma and many more are some of the factors which are responsible for the growth of the market during the forecast period.
This report presents a comprehensive overview, market shares, and growth opportunities of Inhaled Corticosteroid market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
What is the 10-year outlook for the global Inhaled Corticosteroid market?
What factors are driving Inhaled Corticosteroid market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Inhaled Corticosteroid market opportunities vary by end market size?
How does Inhaled Corticosteroid break out type, application?
Asthma is a disease of the entire respiratory tract, including large, intermediate and small airways. Asthma led to inflammation and obstruction of respiratory tract. Patients have various treatment options for asthma, particularly for young and elderly patients. Hence this has led to significant interest on the part of the inhaler device which is easy to use. Inhaled corticosteroid is the most commonly used tool for the treatment of asthma. As with increasing pollution and increasing incidences of asthma, many companies are engaged in the development of new inhaler corticosteroid devices.
The global Inhaled Corticosteroid market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Inhaled Corticosteroid Industry Forecast” looks at past sales and reviews total world Inhaled Corticosteroid sales in 2023, providing a comprehensive analysis by region and market sector of projected Inhaled Corticosteroid sales for 2024 through 2030. With Inhaled Corticosteroid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inhaled Corticosteroid industry.
This Insight Report provides a comprehensive analysis of the global Inhaled Corticosteroid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Inhaled Corticosteroid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Inhaled Corticosteroid market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inhaled Corticosteroid and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inhaled Corticosteroid.
In terms of market value, North America will dominate the inhaler corticosteroid device market during the forecast period. Increasing incidences of life-threatening illness such as chronic obstructive pulmonary disease, asthma and many more are some of the factors which are responsible for the growth of the market during the forecast period.
This report presents a comprehensive overview, market shares, and growth opportunities of Inhaled Corticosteroid market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
- Beclomethasone Dipropionate
- Budesonide
- Fluticasone Inhaler Powder
- Mometasone
- Others
- Hospitals
- Clinics
- Respiratory Care Centers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sumitomo
- Pfizer
- Novartis
- Merck
- Sanofi
- Johnson and Johnson
- GSK
- AstraZeneca
- Teijin
- Glaxo's Advair
- Amgen
- Kos Pharmaceutical
- Teva Pharmaceutical
What is the 10-year outlook for the global Inhaled Corticosteroid market?
What factors are driving Inhaled Corticosteroid market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Inhaled Corticosteroid market opportunities vary by end market size?
How does Inhaled Corticosteroid break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Inhaled Corticosteroid Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Inhaled Corticosteroid by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Inhaled Corticosteroid by Country/Region, 2019, 2023 & 2030
2.2 Inhaled Corticosteroid Segment by Type
2.2.1 Beclomethasone Dipropionate
2.2.2 Budesonide
2.2.3 Fluticasone Inhaler Powder
2.2.4 Mometasone
2.2.5 Others
2.3 Inhaled Corticosteroid Sales by Type
2.3.1 Global Inhaled Corticosteroid Sales Market Share by Type (2019-2024)
2.3.2 Global Inhaled Corticosteroid Revenue and Market Share by Type (2019-2024)
2.3.3 Global Inhaled Corticosteroid Sale Price by Type (2019-2024)
2.4 Inhaled Corticosteroid Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Respiratory Care Centers
2.4.4 Others
2.5 Inhaled Corticosteroid Sales by Application
2.5.1 Global Inhaled Corticosteroid Sale Market Share by Application (2019-2024)
2.5.2 Global Inhaled Corticosteroid Revenue and Market Share by Application (2019-2024)
2.5.3 Global Inhaled Corticosteroid Sale Price by Application (2019-2024)
3 GLOBAL INHALED CORTICOSTEROID BY COMPANY
3.1 Global Inhaled Corticosteroid Breakdown Data by Company
3.1.1 Global Inhaled Corticosteroid Annual Sales by Company (2019-2024)
3.1.2 Global Inhaled Corticosteroid Sales Market Share by Company (2019-2024)
3.2 Global Inhaled Corticosteroid Annual Revenue by Company (2019-2024)
3.2.1 Global Inhaled Corticosteroid Revenue by Company (2019-2024)
3.2.2 Global Inhaled Corticosteroid Revenue Market Share by Company (2019-2024)
3.3 Global Inhaled Corticosteroid Sale Price by Company
3.4 Key Manufacturers Inhaled Corticosteroid Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Inhaled Corticosteroid Product Location Distribution
3.4.2 Players Inhaled Corticosteroid Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INHALED CORTICOSTEROID BY GEOGRAPHIC REGION
4.1 World Historic Inhaled Corticosteroid Market Size by Geographic Region (2019-2024)
4.1.1 Global Inhaled Corticosteroid Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Inhaled Corticosteroid Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Inhaled Corticosteroid Market Size by Country/Region (2019-2024)
4.2.1 Global Inhaled Corticosteroid Annual Sales by Country/Region (2019-2024)
4.2.2 Global Inhaled Corticosteroid Annual Revenue by Country/Region (2019-2024)
4.3 Americas Inhaled Corticosteroid Sales Growth
4.4 APAC Inhaled Corticosteroid Sales Growth
4.5 Europe Inhaled Corticosteroid Sales Growth
4.6 Middle East & Africa Inhaled Corticosteroid Sales Growth
5 AMERICAS
5.1 Americas Inhaled Corticosteroid Sales by Country
5.1.1 Americas Inhaled Corticosteroid Sales by Country (2019-2024)
5.1.2 Americas Inhaled Corticosteroid Revenue by Country (2019-2024)
5.2 Americas Inhaled Corticosteroid Sales by Type
5.3 Americas Inhaled Corticosteroid Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inhaled Corticosteroid Sales by Region
6.1.1 APAC Inhaled Corticosteroid Sales by Region (2019-2024)
6.1.2 APAC Inhaled Corticosteroid Revenue by Region (2019-2024)
6.2 APAC Inhaled Corticosteroid Sales by Type
6.3 APAC Inhaled Corticosteroid Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Inhaled Corticosteroid by Country
7.1.1 Europe Inhaled Corticosteroid Sales by Country (2019-2024)
7.1.2 Europe Inhaled Corticosteroid Revenue by Country (2019-2024)
7.2 Europe Inhaled Corticosteroid Sales by Type
7.3 Europe Inhaled Corticosteroid Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Inhaled Corticosteroid by Country
8.1.1 Middle East & Africa Inhaled Corticosteroid Sales by Country (2019-2024)
8.1.2 Middle East & Africa Inhaled Corticosteroid Revenue by Country (2019-2024)
8.2 Middle East & Africa Inhaled Corticosteroid Sales by Type
8.3 Middle East & Africa Inhaled Corticosteroid Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inhaled Corticosteroid
10.3 Manufacturing Process Analysis of Inhaled Corticosteroid
10.4 Industry Chain Structure of Inhaled Corticosteroid
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Inhaled Corticosteroid Distributors
11.3 Inhaled Corticosteroid Customer
12 WORLD FORECAST REVIEW FOR INHALED CORTICOSTEROID BY GEOGRAPHIC REGION
12.1 Global Inhaled Corticosteroid Market Size Forecast by Region
12.1.1 Global Inhaled Corticosteroid Forecast by Region (2025-2030)
12.1.2 Global Inhaled Corticosteroid Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Inhaled Corticosteroid Forecast by Type
12.7 Global Inhaled Corticosteroid Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sumitomo
13.1.1 Sumitomo Company Information
13.1.2 Sumitomo Inhaled Corticosteroid Product Portfolios and Specifications
13.1.3 Sumitomo Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sumitomo Main Business Overview
13.1.5 Sumitomo Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Inhaled Corticosteroid Product Portfolios and Specifications
13.2.3 Pfizer Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Inhaled Corticosteroid Product Portfolios and Specifications
13.3.3 Novartis Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Inhaled Corticosteroid Product Portfolios and Specifications
13.4.3 Merck Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Inhaled Corticosteroid Product Portfolios and Specifications
13.5.3 Sanofi Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Johnson and Johnson
13.6.1 Johnson and Johnson Company Information
13.6.2 Johnson and Johnson Inhaled Corticosteroid Product Portfolios and Specifications
13.6.3 Johnson and Johnson Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Johnson and Johnson Main Business Overview
13.6.5 Johnson and Johnson Latest Developments
13.7 GSK
13.7.1 GSK Company Information
13.7.2 GSK Inhaled Corticosteroid Product Portfolios and Specifications
13.7.3 GSK Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 GSK Main Business Overview
13.7.5 GSK Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca Inhaled Corticosteroid Product Portfolios and Specifications
13.8.3 AstraZeneca Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 Teijin
13.9.1 Teijin Company Information
13.9.2 Teijin Inhaled Corticosteroid Product Portfolios and Specifications
13.9.3 Teijin Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Teijin Main Business Overview
13.9.5 Teijin Latest Developments
13.10 Glaxo's Advair
13.10.1 Glaxo's Advair Company Information
13.10.2 Glaxo's Advair Inhaled Corticosteroid Product Portfolios and Specifications
13.10.3 Glaxo's Advair Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Glaxo's Advair Main Business Overview
13.10.5 Glaxo's Advair Latest Developments
13.11 Amgen
13.11.1 Amgen Company Information
13.11.2 Amgen Inhaled Corticosteroid Product Portfolios and Specifications
13.11.3 Amgen Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Amgen Main Business Overview
13.11.5 Amgen Latest Developments
13.12 Kos Pharmaceutical
13.12.1 Kos Pharmaceutical Company Information
13.12.2 Kos Pharmaceutical Inhaled Corticosteroid Product Portfolios and Specifications
13.12.3 Kos Pharmaceutical Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Kos Pharmaceutical Main Business Overview
13.12.5 Kos Pharmaceutical Latest Developments
13.13 Teva Pharmaceutical
13.13.1 Teva Pharmaceutical Company Information
13.13.2 Teva Pharmaceutical Inhaled Corticosteroid Product Portfolios and Specifications
13.13.3 Teva Pharmaceutical Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Teva Pharmaceutical Main Business Overview
13.13.5 Teva Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Inhaled Corticosteroid Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Inhaled Corticosteroid by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Inhaled Corticosteroid by Country/Region, 2019, 2023 & 2030
2.2 Inhaled Corticosteroid Segment by Type
2.2.1 Beclomethasone Dipropionate
2.2.2 Budesonide
2.2.3 Fluticasone Inhaler Powder
2.2.4 Mometasone
2.2.5 Others
2.3 Inhaled Corticosteroid Sales by Type
2.3.1 Global Inhaled Corticosteroid Sales Market Share by Type (2019-2024)
2.3.2 Global Inhaled Corticosteroid Revenue and Market Share by Type (2019-2024)
2.3.3 Global Inhaled Corticosteroid Sale Price by Type (2019-2024)
2.4 Inhaled Corticosteroid Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Respiratory Care Centers
2.4.4 Others
2.5 Inhaled Corticosteroid Sales by Application
2.5.1 Global Inhaled Corticosteroid Sale Market Share by Application (2019-2024)
2.5.2 Global Inhaled Corticosteroid Revenue and Market Share by Application (2019-2024)
2.5.3 Global Inhaled Corticosteroid Sale Price by Application (2019-2024)
3 GLOBAL INHALED CORTICOSTEROID BY COMPANY
3.1 Global Inhaled Corticosteroid Breakdown Data by Company
3.1.1 Global Inhaled Corticosteroid Annual Sales by Company (2019-2024)
3.1.2 Global Inhaled Corticosteroid Sales Market Share by Company (2019-2024)
3.2 Global Inhaled Corticosteroid Annual Revenue by Company (2019-2024)
3.2.1 Global Inhaled Corticosteroid Revenue by Company (2019-2024)
3.2.2 Global Inhaled Corticosteroid Revenue Market Share by Company (2019-2024)
3.3 Global Inhaled Corticosteroid Sale Price by Company
3.4 Key Manufacturers Inhaled Corticosteroid Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Inhaled Corticosteroid Product Location Distribution
3.4.2 Players Inhaled Corticosteroid Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INHALED CORTICOSTEROID BY GEOGRAPHIC REGION
4.1 World Historic Inhaled Corticosteroid Market Size by Geographic Region (2019-2024)
4.1.1 Global Inhaled Corticosteroid Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Inhaled Corticosteroid Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Inhaled Corticosteroid Market Size by Country/Region (2019-2024)
4.2.1 Global Inhaled Corticosteroid Annual Sales by Country/Region (2019-2024)
4.2.2 Global Inhaled Corticosteroid Annual Revenue by Country/Region (2019-2024)
4.3 Americas Inhaled Corticosteroid Sales Growth
4.4 APAC Inhaled Corticosteroid Sales Growth
4.5 Europe Inhaled Corticosteroid Sales Growth
4.6 Middle East & Africa Inhaled Corticosteroid Sales Growth
5 AMERICAS
5.1 Americas Inhaled Corticosteroid Sales by Country
5.1.1 Americas Inhaled Corticosteroid Sales by Country (2019-2024)
5.1.2 Americas Inhaled Corticosteroid Revenue by Country (2019-2024)
5.2 Americas Inhaled Corticosteroid Sales by Type
5.3 Americas Inhaled Corticosteroid Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inhaled Corticosteroid Sales by Region
6.1.1 APAC Inhaled Corticosteroid Sales by Region (2019-2024)
6.1.2 APAC Inhaled Corticosteroid Revenue by Region (2019-2024)
6.2 APAC Inhaled Corticosteroid Sales by Type
6.3 APAC Inhaled Corticosteroid Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Inhaled Corticosteroid by Country
7.1.1 Europe Inhaled Corticosteroid Sales by Country (2019-2024)
7.1.2 Europe Inhaled Corticosteroid Revenue by Country (2019-2024)
7.2 Europe Inhaled Corticosteroid Sales by Type
7.3 Europe Inhaled Corticosteroid Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Inhaled Corticosteroid by Country
8.1.1 Middle East & Africa Inhaled Corticosteroid Sales by Country (2019-2024)
8.1.2 Middle East & Africa Inhaled Corticosteroid Revenue by Country (2019-2024)
8.2 Middle East & Africa Inhaled Corticosteroid Sales by Type
8.3 Middle East & Africa Inhaled Corticosteroid Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inhaled Corticosteroid
10.3 Manufacturing Process Analysis of Inhaled Corticosteroid
10.4 Industry Chain Structure of Inhaled Corticosteroid
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Inhaled Corticosteroid Distributors
11.3 Inhaled Corticosteroid Customer
12 WORLD FORECAST REVIEW FOR INHALED CORTICOSTEROID BY GEOGRAPHIC REGION
12.1 Global Inhaled Corticosteroid Market Size Forecast by Region
12.1.1 Global Inhaled Corticosteroid Forecast by Region (2025-2030)
12.1.2 Global Inhaled Corticosteroid Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Inhaled Corticosteroid Forecast by Type
12.7 Global Inhaled Corticosteroid Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sumitomo
13.1.1 Sumitomo Company Information
13.1.2 Sumitomo Inhaled Corticosteroid Product Portfolios and Specifications
13.1.3 Sumitomo Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sumitomo Main Business Overview
13.1.5 Sumitomo Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Inhaled Corticosteroid Product Portfolios and Specifications
13.2.3 Pfizer Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Inhaled Corticosteroid Product Portfolios and Specifications
13.3.3 Novartis Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Inhaled Corticosteroid Product Portfolios and Specifications
13.4.3 Merck Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Inhaled Corticosteroid Product Portfolios and Specifications
13.5.3 Sanofi Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Johnson and Johnson
13.6.1 Johnson and Johnson Company Information
13.6.2 Johnson and Johnson Inhaled Corticosteroid Product Portfolios and Specifications
13.6.3 Johnson and Johnson Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Johnson and Johnson Main Business Overview
13.6.5 Johnson and Johnson Latest Developments
13.7 GSK
13.7.1 GSK Company Information
13.7.2 GSK Inhaled Corticosteroid Product Portfolios and Specifications
13.7.3 GSK Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 GSK Main Business Overview
13.7.5 GSK Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca Inhaled Corticosteroid Product Portfolios and Specifications
13.8.3 AstraZeneca Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 Teijin
13.9.1 Teijin Company Information
13.9.2 Teijin Inhaled Corticosteroid Product Portfolios and Specifications
13.9.3 Teijin Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Teijin Main Business Overview
13.9.5 Teijin Latest Developments
13.10 Glaxo's Advair
13.10.1 Glaxo's Advair Company Information
13.10.2 Glaxo's Advair Inhaled Corticosteroid Product Portfolios and Specifications
13.10.3 Glaxo's Advair Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Glaxo's Advair Main Business Overview
13.10.5 Glaxo's Advair Latest Developments
13.11 Amgen
13.11.1 Amgen Company Information
13.11.2 Amgen Inhaled Corticosteroid Product Portfolios and Specifications
13.11.3 Amgen Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Amgen Main Business Overview
13.11.5 Amgen Latest Developments
13.12 Kos Pharmaceutical
13.12.1 Kos Pharmaceutical Company Information
13.12.2 Kos Pharmaceutical Inhaled Corticosteroid Product Portfolios and Specifications
13.12.3 Kos Pharmaceutical Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Kos Pharmaceutical Main Business Overview
13.12.5 Kos Pharmaceutical Latest Developments
13.13 Teva Pharmaceutical
13.13.1 Teva Pharmaceutical Company Information
13.13.2 Teva Pharmaceutical Inhaled Corticosteroid Product Portfolios and Specifications
13.13.3 Teva Pharmaceutical Inhaled Corticosteroid Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Teva Pharmaceutical Main Business Overview
13.13.5 Teva Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Inhaled Corticosteroid Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Inhaled Corticosteroid Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Beclomethasone Dipropionate
Table 4. Major Players of Budesonide
Table 5. Major Players of Fluticasone Inhaler Powder
Table 6. Major Players of Mometasone
Table 7. Major Players of Others
Table 8. Global Inhaled Corticosteroid Sales by Type (2019-2024) & (MT)
Table 9. Global Inhaled Corticosteroid Sales Market Share by Type (2019-2024)
Table 10. Global Inhaled Corticosteroid Revenue by Type (2019-2024) & ($ million)
Table 11. Global Inhaled Corticosteroid Revenue Market Share by Type (2019-2024)
Table 12. Global Inhaled Corticosteroid Sale Price by Type (2019-2024) & (USD/MT)
Table 13. Global Inhaled Corticosteroid Sales by Application (2019-2024) & (MT)
Table 14. Global Inhaled Corticosteroid Sales Market Share by Application (2019-2024)
Table 15. Global Inhaled Corticosteroid Revenue by Application (2019-2024)
Table 16. Global Inhaled Corticosteroid Revenue Market Share by Application (2019-2024)
Table 17. Global Inhaled Corticosteroid Sale Price by Application (2019-2024) & (USD/MT)
Table 18. Global Inhaled Corticosteroid Sales by Company (2019-2024) & (MT)
Table 19. Global Inhaled Corticosteroid Sales Market Share by Company (2019-2024)
Table 20. Global Inhaled Corticosteroid Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Inhaled Corticosteroid Revenue Market Share by Company (2019-2024)
Table 22. Global Inhaled Corticosteroid Sale Price by Company (2019-2024) & (USD/MT)
Table 23. Key Manufacturers Inhaled Corticosteroid Producing Area Distribution and Sales Area
Table 24. Players Inhaled Corticosteroid Products Offered
Table 25. Inhaled Corticosteroid Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Inhaled Corticosteroid Sales by Geographic Region (2019-2024) & (MT)
Table 29. Global Inhaled Corticosteroid Sales Market Share Geographic Region (2019-2024)
Table 30. Global Inhaled Corticosteroid Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Inhaled Corticosteroid Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Inhaled Corticosteroid Sales by Country/Region (2019-2024) & (MT)
Table 33. Global Inhaled Corticosteroid Sales Market Share by Country/Region (2019-2024)
Table 34. Global Inhaled Corticosteroid Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Inhaled Corticosteroid Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Inhaled Corticosteroid Sales by Country (2019-2024) & (MT)
Table 37. Americas Inhaled Corticosteroid Sales Market Share by Country (2019-2024)
Table 38. Americas Inhaled Corticosteroid Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Inhaled Corticosteroid Revenue Market Share by Country (2019-2024)
Table 40. Americas Inhaled Corticosteroid Sales by Type (2019-2024) & (MT)
Table 41. Americas Inhaled Corticosteroid Sales by Application (2019-2024) & (MT)
Table 42. APAC Inhaled Corticosteroid Sales by Region (2019-2024) & (MT)
Table 43. APAC Inhaled Corticosteroid Sales Market Share by Region (2019-2024)
Table 44. APAC Inhaled Corticosteroid Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Inhaled Corticosteroid Revenue Market Share by Region (2019-2024)
Table 46. APAC Inhaled Corticosteroid Sales by Type (2019-2024) & (MT)
Table 47. APAC Inhaled Corticosteroid Sales by Application (2019-2024) & (MT)
Table 48. Europe Inhaled Corticosteroid Sales by Country (2019-2024) & (MT)
Table 49. Europe Inhaled Corticosteroid Sales Market Share by Country (2019-2024)
Table 50. Europe Inhaled Corticosteroid Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Inhaled Corticosteroid Revenue Market Share by Country (2019-2024)
Table 52. Europe Inhaled Corticosteroid Sales by Type (2019-2024) & (MT)
Table 53. Europe Inhaled Corticosteroid Sales by Application (2019-2024) & (MT)
Table 54. Middle East & Africa Inhaled Corticosteroid Sales by Country (2019-2024) & (MT)
Table 55. Middle East & Africa Inhaled Corticosteroid Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Inhaled Corticosteroid Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Inhaled Corticosteroid Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Inhaled Corticosteroid Sales by Type (2019-2024) & (MT)
Table 59. Middle East & Africa Inhaled Corticosteroid Sales by Application (2019-2024) & (MT)
Table 60. Key Market Drivers & Growth Opportunities of Inhaled Corticosteroid
Table 61. Key Market Challenges & Risks of Inhaled Corticosteroid
Table 62. Key Industry Trends of Inhaled Corticosteroid
Table 63. Inhaled Corticosteroid Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Inhaled Corticosteroid Distributors List
Table 66. Inhaled Corticosteroid Customer List
Table 67. Global Inhaled Corticosteroid Sales Forecast by Region (2025-2030) & (MT)
Table 68. Global Inhaled Corticosteroid Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Inhaled Corticosteroid Sales Forecast by Country (2025-2030) & (MT)
Table 70. Americas Inhaled Corticosteroid Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Inhaled Corticosteroid Sales Forecast by Region (2025-2030) & (MT)
Table 72. APAC Inhaled Corticosteroid Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Inhaled Corticosteroid Sales Forecast by Country (2025-2030) & (MT)
Table 74. Europe Inhaled Corticosteroid Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Inhaled Corticosteroid Sales Forecast by Country (2025-2030) & (MT)
Table 76. Middle East & Africa Inhaled Corticosteroid Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Inhaled Corticosteroid Sales Forecast by Type (2025-2030) & (MT)
Table 78. Global Inhaled Corticosteroid Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Inhaled Corticosteroid Sales Forecast by Application (2025-2030) & (MT)
Table 80. Global Inhaled Corticosteroid Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Sumitomo Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 82. Sumitomo Inhaled Corticosteroid Product Portfolios and Specifications
Table 83. Sumitomo Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 84. Sumitomo Main Business
Table 85. Sumitomo Latest Developments
Table 86. Pfizer Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 87. Pfizer Inhaled Corticosteroid Product Portfolios and Specifications
Table 88. Pfizer Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 89. Pfizer Main Business
Table 90. Pfizer Latest Developments
Table 91. Novartis Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 92. Novartis Inhaled Corticosteroid Product Portfolios and Specifications
Table 93. Novartis Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 94. Novartis Main Business
Table 95. Novartis Latest Developments
Table 96. Merck Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 97. Merck Inhaled Corticosteroid Product Portfolios and Specifications
Table 98. Merck Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 99. Merck Main Business
Table 100. Merck Latest Developments
Table 101. Sanofi Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 102. Sanofi Inhaled Corticosteroid Product Portfolios and Specifications
Table 103. Sanofi Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 104. Sanofi Main Business
Table 105. Sanofi Latest Developments
Table 106. Johnson and Johnson Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 107. Johnson and Johnson Inhaled Corticosteroid Product Portfolios and Specifications
Table 108. Johnson and Johnson Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 109. Johnson and Johnson Main Business
Table 110. Johnson and Johnson Latest Developments
Table 111. GSK Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 112. GSK Inhaled Corticosteroid Product Portfolios and Specifications
Table 113. GSK Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 114. GSK Main Business
Table 115. GSK Latest Developments
Table 116. AstraZeneca Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 117. AstraZeneca Inhaled Corticosteroid Product Portfolios and Specifications
Table 118. AstraZeneca Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 119. AstraZeneca Main Business
Table 120. AstraZeneca Latest Developments
Table 121. Teijin Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 122. Teijin Inhaled Corticosteroid Product Portfolios and Specifications
Table 123. Teijin Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 124. Teijin Main Business
Table 125. Teijin Latest Developments
Table 126. Glaxo's Advair Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 127. Glaxo's Advair Inhaled Corticosteroid Product Portfolios and Specifications
Table 128. Glaxo's Advair Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 129. Glaxo's Advair Main Business
Table 130. Glaxo's Advair Latest Developments
Table 131. Amgen Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 132. Amgen Inhaled Corticosteroid Product Portfolios and Specifications
Table 133. Amgen Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 134. Amgen Main Business
Table 135. Amgen Latest Developments
Table 136. Kos Pharmaceutical Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 137. Kos Pharmaceutical Inhaled Corticosteroid Product Portfolios and Specifications
Table 138. Kos Pharmaceutical Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 139. Kos Pharmaceutical Main Business
Table 140. Kos Pharmaceutical Latest Developments
Table 141. Teva Pharmaceutical Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 142. Teva Pharmaceutical Inhaled Corticosteroid Product Portfolios and Specifications
Table 143. Teva Pharmaceutical Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 144. Teva Pharmaceutical Main Business
Table 145. Teva Pharmaceutical Latest Developments
Table 1. Inhaled Corticosteroid Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Inhaled Corticosteroid Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Beclomethasone Dipropionate
Table 4. Major Players of Budesonide
Table 5. Major Players of Fluticasone Inhaler Powder
Table 6. Major Players of Mometasone
Table 7. Major Players of Others
Table 8. Global Inhaled Corticosteroid Sales by Type (2019-2024) & (MT)
Table 9. Global Inhaled Corticosteroid Sales Market Share by Type (2019-2024)
Table 10. Global Inhaled Corticosteroid Revenue by Type (2019-2024) & ($ million)
Table 11. Global Inhaled Corticosteroid Revenue Market Share by Type (2019-2024)
Table 12. Global Inhaled Corticosteroid Sale Price by Type (2019-2024) & (USD/MT)
Table 13. Global Inhaled Corticosteroid Sales by Application (2019-2024) & (MT)
Table 14. Global Inhaled Corticosteroid Sales Market Share by Application (2019-2024)
Table 15. Global Inhaled Corticosteroid Revenue by Application (2019-2024)
Table 16. Global Inhaled Corticosteroid Revenue Market Share by Application (2019-2024)
Table 17. Global Inhaled Corticosteroid Sale Price by Application (2019-2024) & (USD/MT)
Table 18. Global Inhaled Corticosteroid Sales by Company (2019-2024) & (MT)
Table 19. Global Inhaled Corticosteroid Sales Market Share by Company (2019-2024)
Table 20. Global Inhaled Corticosteroid Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Inhaled Corticosteroid Revenue Market Share by Company (2019-2024)
Table 22. Global Inhaled Corticosteroid Sale Price by Company (2019-2024) & (USD/MT)
Table 23. Key Manufacturers Inhaled Corticosteroid Producing Area Distribution and Sales Area
Table 24. Players Inhaled Corticosteroid Products Offered
Table 25. Inhaled Corticosteroid Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Inhaled Corticosteroid Sales by Geographic Region (2019-2024) & (MT)
Table 29. Global Inhaled Corticosteroid Sales Market Share Geographic Region (2019-2024)
Table 30. Global Inhaled Corticosteroid Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Inhaled Corticosteroid Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Inhaled Corticosteroid Sales by Country/Region (2019-2024) & (MT)
Table 33. Global Inhaled Corticosteroid Sales Market Share by Country/Region (2019-2024)
Table 34. Global Inhaled Corticosteroid Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Inhaled Corticosteroid Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Inhaled Corticosteroid Sales by Country (2019-2024) & (MT)
Table 37. Americas Inhaled Corticosteroid Sales Market Share by Country (2019-2024)
Table 38. Americas Inhaled Corticosteroid Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Inhaled Corticosteroid Revenue Market Share by Country (2019-2024)
Table 40. Americas Inhaled Corticosteroid Sales by Type (2019-2024) & (MT)
Table 41. Americas Inhaled Corticosteroid Sales by Application (2019-2024) & (MT)
Table 42. APAC Inhaled Corticosteroid Sales by Region (2019-2024) & (MT)
Table 43. APAC Inhaled Corticosteroid Sales Market Share by Region (2019-2024)
Table 44. APAC Inhaled Corticosteroid Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Inhaled Corticosteroid Revenue Market Share by Region (2019-2024)
Table 46. APAC Inhaled Corticosteroid Sales by Type (2019-2024) & (MT)
Table 47. APAC Inhaled Corticosteroid Sales by Application (2019-2024) & (MT)
Table 48. Europe Inhaled Corticosteroid Sales by Country (2019-2024) & (MT)
Table 49. Europe Inhaled Corticosteroid Sales Market Share by Country (2019-2024)
Table 50. Europe Inhaled Corticosteroid Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Inhaled Corticosteroid Revenue Market Share by Country (2019-2024)
Table 52. Europe Inhaled Corticosteroid Sales by Type (2019-2024) & (MT)
Table 53. Europe Inhaled Corticosteroid Sales by Application (2019-2024) & (MT)
Table 54. Middle East & Africa Inhaled Corticosteroid Sales by Country (2019-2024) & (MT)
Table 55. Middle East & Africa Inhaled Corticosteroid Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Inhaled Corticosteroid Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Inhaled Corticosteroid Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Inhaled Corticosteroid Sales by Type (2019-2024) & (MT)
Table 59. Middle East & Africa Inhaled Corticosteroid Sales by Application (2019-2024) & (MT)
Table 60. Key Market Drivers & Growth Opportunities of Inhaled Corticosteroid
Table 61. Key Market Challenges & Risks of Inhaled Corticosteroid
Table 62. Key Industry Trends of Inhaled Corticosteroid
Table 63. Inhaled Corticosteroid Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Inhaled Corticosteroid Distributors List
Table 66. Inhaled Corticosteroid Customer List
Table 67. Global Inhaled Corticosteroid Sales Forecast by Region (2025-2030) & (MT)
Table 68. Global Inhaled Corticosteroid Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Inhaled Corticosteroid Sales Forecast by Country (2025-2030) & (MT)
Table 70. Americas Inhaled Corticosteroid Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Inhaled Corticosteroid Sales Forecast by Region (2025-2030) & (MT)
Table 72. APAC Inhaled Corticosteroid Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Inhaled Corticosteroid Sales Forecast by Country (2025-2030) & (MT)
Table 74. Europe Inhaled Corticosteroid Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Inhaled Corticosteroid Sales Forecast by Country (2025-2030) & (MT)
Table 76. Middle East & Africa Inhaled Corticosteroid Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Inhaled Corticosteroid Sales Forecast by Type (2025-2030) & (MT)
Table 78. Global Inhaled Corticosteroid Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Inhaled Corticosteroid Sales Forecast by Application (2025-2030) & (MT)
Table 80. Global Inhaled Corticosteroid Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Sumitomo Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 82. Sumitomo Inhaled Corticosteroid Product Portfolios and Specifications
Table 83. Sumitomo Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 84. Sumitomo Main Business
Table 85. Sumitomo Latest Developments
Table 86. Pfizer Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 87. Pfizer Inhaled Corticosteroid Product Portfolios and Specifications
Table 88. Pfizer Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 89. Pfizer Main Business
Table 90. Pfizer Latest Developments
Table 91. Novartis Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 92. Novartis Inhaled Corticosteroid Product Portfolios and Specifications
Table 93. Novartis Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 94. Novartis Main Business
Table 95. Novartis Latest Developments
Table 96. Merck Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 97. Merck Inhaled Corticosteroid Product Portfolios and Specifications
Table 98. Merck Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 99. Merck Main Business
Table 100. Merck Latest Developments
Table 101. Sanofi Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 102. Sanofi Inhaled Corticosteroid Product Portfolios and Specifications
Table 103. Sanofi Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 104. Sanofi Main Business
Table 105. Sanofi Latest Developments
Table 106. Johnson and Johnson Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 107. Johnson and Johnson Inhaled Corticosteroid Product Portfolios and Specifications
Table 108. Johnson and Johnson Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 109. Johnson and Johnson Main Business
Table 110. Johnson and Johnson Latest Developments
Table 111. GSK Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 112. GSK Inhaled Corticosteroid Product Portfolios and Specifications
Table 113. GSK Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 114. GSK Main Business
Table 115. GSK Latest Developments
Table 116. AstraZeneca Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 117. AstraZeneca Inhaled Corticosteroid Product Portfolios and Specifications
Table 118. AstraZeneca Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 119. AstraZeneca Main Business
Table 120. AstraZeneca Latest Developments
Table 121. Teijin Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 122. Teijin Inhaled Corticosteroid Product Portfolios and Specifications
Table 123. Teijin Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 124. Teijin Main Business
Table 125. Teijin Latest Developments
Table 126. Glaxo's Advair Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 127. Glaxo's Advair Inhaled Corticosteroid Product Portfolios and Specifications
Table 128. Glaxo's Advair Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 129. Glaxo's Advair Main Business
Table 130. Glaxo's Advair Latest Developments
Table 131. Amgen Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 132. Amgen Inhaled Corticosteroid Product Portfolios and Specifications
Table 133. Amgen Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 134. Amgen Main Business
Table 135. Amgen Latest Developments
Table 136. Kos Pharmaceutical Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 137. Kos Pharmaceutical Inhaled Corticosteroid Product Portfolios and Specifications
Table 138. Kos Pharmaceutical Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 139. Kos Pharmaceutical Main Business
Table 140. Kos Pharmaceutical Latest Developments
Table 141. Teva Pharmaceutical Basic Information, Inhaled Corticosteroid Manufacturing Base, Sales Area and Its Competitors
Table 142. Teva Pharmaceutical Inhaled Corticosteroid Product Portfolios and Specifications
Table 143. Teva Pharmaceutical Inhaled Corticosteroid Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 144. Teva Pharmaceutical Main Business
Table 145. Teva Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Inhaled Corticosteroid
Figure 2. Inhaled Corticosteroid Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Inhaled Corticosteroid Sales Growth Rate 2019-2030 (MT)
Figure 7. Global Inhaled Corticosteroid Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Inhaled Corticosteroid Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Beclomethasone Dipropionate
Figure 10. Product Picture of Budesonide
Figure 11. Product Picture of Fluticasone Inhaler Powder
Figure 12. Product Picture of Mometasone
Figure 13. Product Picture of Others
Figure 14. Global Inhaled Corticosteroid Sales Market Share by Type in 2023
Figure 15. Global Inhaled Corticosteroid Revenue Market Share by Type (2019-2024)
Figure 16. Inhaled Corticosteroid Consumed in Hospitals
Figure 17. Global Inhaled Corticosteroid Market: Hospitals (2019-2024) & (MT)
Figure 18. Inhaled Corticosteroid Consumed in Clinics
Figure 19. Global Inhaled Corticosteroid Market: Clinics (2019-2024) & (MT)
Figure 20. Inhaled Corticosteroid Consumed in Respiratory Care Centers
Figure 21. Global Inhaled Corticosteroid Market: Respiratory Care Centers (2019-2024) & (MT)
Figure 22. Inhaled Corticosteroid Consumed in Others
Figure 23. Global Inhaled Corticosteroid Market: Others (2019-2024) & (MT)
Figure 24. Global Inhaled Corticosteroid Sales Market Share by Application (2023)
Figure 25. Global Inhaled Corticosteroid Revenue Market Share by Application in 2023
Figure 26. Inhaled Corticosteroid Sales Market by Company in 2023 (MT)
Figure 27. Global Inhaled Corticosteroid Sales Market Share by Company in 2023
Figure 28. Inhaled Corticosteroid Revenue Market by Company in 2023 ($ Million)
Figure 29. Global Inhaled Corticosteroid Revenue Market Share by Company in 2023
Figure 30. Global Inhaled Corticosteroid Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Inhaled Corticosteroid Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Inhaled Corticosteroid Sales 2019-2024 (MT)
Figure 33. Americas Inhaled Corticosteroid Revenue 2019-2024 ($ Millions)
Figure 34. APAC Inhaled Corticosteroid Sales 2019-2024 (MT)
Figure 35. APAC Inhaled Corticosteroid Revenue 2019-2024 ($ Millions)
Figure 36. Europe Inhaled Corticosteroid Sales 2019-2024 (MT)
Figure 37. Europe Inhaled Corticosteroid Revenue 2019-2024 ($ Millions)
Figure 38. Middle East & Africa Inhaled Corticosteroid Sales 2019-2024 (MT)
Figure 39. Middle East & Africa Inhaled Corticosteroid Revenue 2019-2024 ($ Millions)
Figure 40. Americas Inhaled Corticosteroid Sales Market Share by Country in 2023
Figure 41. Americas Inhaled Corticosteroid Revenue Market Share by Country in 2023
Figure 42. Americas Inhaled Corticosteroid Sales Market Share by Type (2019-2024)
Figure 43. Americas Inhaled Corticosteroid Sales Market Share by Application (2019-2024)
Figure 44. United States Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 45. Canada Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 46. Mexico Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 47. Brazil Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 48. APAC Inhaled Corticosteroid Sales Market Share by Region in 2023
Figure 49. APAC Inhaled Corticosteroid Revenue Market Share by Regions in 2023
Figure 50. APAC Inhaled Corticosteroid Sales Market Share by Type (2019-2024)
Figure 51. APAC Inhaled Corticosteroid Sales Market Share by Application (2019-2024)
Figure 52. China Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 53. Japan Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 54. South Korea Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 55. Southeast Asia Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 56. India Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 57. Australia Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 58. China Taiwan Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 59. Europe Inhaled Corticosteroid Sales Market Share by Country in 2023
Figure 60. Europe Inhaled Corticosteroid Revenue Market Share by Country in 2023
Figure 61. Europe Inhaled Corticosteroid Sales Market Share by Type (2019-2024)
Figure 62. Europe Inhaled Corticosteroid Sales Market Share by Application (2019-2024)
Figure 63. Germany Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 64. France Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 65. UK Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 66. Italy Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 67. Russia Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 68. Middle East & Africa Inhaled Corticosteroid Sales Market Share by Country in 2023
Figure 69. Middle East & Africa Inhaled Corticosteroid Revenue Market Share by Country in 2023
Figure 70. Middle East & Africa Inhaled Corticosteroid Sales Market Share by Type (2019-2024)
Figure 71. Middle East & Africa Inhaled Corticosteroid Sales Market Share by Application (2019-2024)
Figure 72. Egypt Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 73. South Africa Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 74. Israel Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 75. Turkey Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 76. GCC Country Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Inhaled Corticosteroid in 2023
Figure 78. Manufacturing Process Analysis of Inhaled Corticosteroid
Figure 79. Industry Chain Structure of Inhaled Corticosteroid
Figure 80. Channels of Distribution
Figure 81. Global Inhaled Corticosteroid Sales Market Forecast by Region (2025-2030)
Figure 82. Global Inhaled Corticosteroid Revenue Market Share Forecast by Region (2025-2030)
Figure 83. Global Inhaled Corticosteroid Sales Market Share Forecast by Type (2025-2030)
Figure 84. Global Inhaled Corticosteroid Revenue Market Share Forecast by Type (2025-2030)
Figure 85. Global Inhaled Corticosteroid Sales Market Share Forecast by Application (2025-2030)
Figure 86. Global Inhaled Corticosteroid Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Inhaled Corticosteroid
Figure 2. Inhaled Corticosteroid Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Inhaled Corticosteroid Sales Growth Rate 2019-2030 (MT)
Figure 7. Global Inhaled Corticosteroid Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Inhaled Corticosteroid Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Beclomethasone Dipropionate
Figure 10. Product Picture of Budesonide
Figure 11. Product Picture of Fluticasone Inhaler Powder
Figure 12. Product Picture of Mometasone
Figure 13. Product Picture of Others
Figure 14. Global Inhaled Corticosteroid Sales Market Share by Type in 2023
Figure 15. Global Inhaled Corticosteroid Revenue Market Share by Type (2019-2024)
Figure 16. Inhaled Corticosteroid Consumed in Hospitals
Figure 17. Global Inhaled Corticosteroid Market: Hospitals (2019-2024) & (MT)
Figure 18. Inhaled Corticosteroid Consumed in Clinics
Figure 19. Global Inhaled Corticosteroid Market: Clinics (2019-2024) & (MT)
Figure 20. Inhaled Corticosteroid Consumed in Respiratory Care Centers
Figure 21. Global Inhaled Corticosteroid Market: Respiratory Care Centers (2019-2024) & (MT)
Figure 22. Inhaled Corticosteroid Consumed in Others
Figure 23. Global Inhaled Corticosteroid Market: Others (2019-2024) & (MT)
Figure 24. Global Inhaled Corticosteroid Sales Market Share by Application (2023)
Figure 25. Global Inhaled Corticosteroid Revenue Market Share by Application in 2023
Figure 26. Inhaled Corticosteroid Sales Market by Company in 2023 (MT)
Figure 27. Global Inhaled Corticosteroid Sales Market Share by Company in 2023
Figure 28. Inhaled Corticosteroid Revenue Market by Company in 2023 ($ Million)
Figure 29. Global Inhaled Corticosteroid Revenue Market Share by Company in 2023
Figure 30. Global Inhaled Corticosteroid Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Inhaled Corticosteroid Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Inhaled Corticosteroid Sales 2019-2024 (MT)
Figure 33. Americas Inhaled Corticosteroid Revenue 2019-2024 ($ Millions)
Figure 34. APAC Inhaled Corticosteroid Sales 2019-2024 (MT)
Figure 35. APAC Inhaled Corticosteroid Revenue 2019-2024 ($ Millions)
Figure 36. Europe Inhaled Corticosteroid Sales 2019-2024 (MT)
Figure 37. Europe Inhaled Corticosteroid Revenue 2019-2024 ($ Millions)
Figure 38. Middle East & Africa Inhaled Corticosteroid Sales 2019-2024 (MT)
Figure 39. Middle East & Africa Inhaled Corticosteroid Revenue 2019-2024 ($ Millions)
Figure 40. Americas Inhaled Corticosteroid Sales Market Share by Country in 2023
Figure 41. Americas Inhaled Corticosteroid Revenue Market Share by Country in 2023
Figure 42. Americas Inhaled Corticosteroid Sales Market Share by Type (2019-2024)
Figure 43. Americas Inhaled Corticosteroid Sales Market Share by Application (2019-2024)
Figure 44. United States Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 45. Canada Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 46. Mexico Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 47. Brazil Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 48. APAC Inhaled Corticosteroid Sales Market Share by Region in 2023
Figure 49. APAC Inhaled Corticosteroid Revenue Market Share by Regions in 2023
Figure 50. APAC Inhaled Corticosteroid Sales Market Share by Type (2019-2024)
Figure 51. APAC Inhaled Corticosteroid Sales Market Share by Application (2019-2024)
Figure 52. China Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 53. Japan Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 54. South Korea Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 55. Southeast Asia Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 56. India Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 57. Australia Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 58. China Taiwan Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 59. Europe Inhaled Corticosteroid Sales Market Share by Country in 2023
Figure 60. Europe Inhaled Corticosteroid Revenue Market Share by Country in 2023
Figure 61. Europe Inhaled Corticosteroid Sales Market Share by Type (2019-2024)
Figure 62. Europe Inhaled Corticosteroid Sales Market Share by Application (2019-2024)
Figure 63. Germany Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 64. France Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 65. UK Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 66. Italy Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 67. Russia Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 68. Middle East & Africa Inhaled Corticosteroid Sales Market Share by Country in 2023
Figure 69. Middle East & Africa Inhaled Corticosteroid Revenue Market Share by Country in 2023
Figure 70. Middle East & Africa Inhaled Corticosteroid Sales Market Share by Type (2019-2024)
Figure 71. Middle East & Africa Inhaled Corticosteroid Sales Market Share by Application (2019-2024)
Figure 72. Egypt Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 73. South Africa Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 74. Israel Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 75. Turkey Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 76. GCC Country Inhaled Corticosteroid Revenue Growth 2019-2024 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Inhaled Corticosteroid in 2023
Figure 78. Manufacturing Process Analysis of Inhaled Corticosteroid
Figure 79. Industry Chain Structure of Inhaled Corticosteroid
Figure 80. Channels of Distribution
Figure 81. Global Inhaled Corticosteroid Sales Market Forecast by Region (2025-2030)
Figure 82. Global Inhaled Corticosteroid Revenue Market Share Forecast by Region (2025-2030)
Figure 83. Global Inhaled Corticosteroid Sales Market Share Forecast by Type (2025-2030)
Figure 84. Global Inhaled Corticosteroid Revenue Market Share Forecast by Type (2025-2030)
Figure 85. Global Inhaled Corticosteroid Sales Market Share Forecast by Application (2025-2030)
Figure 86. Global Inhaled Corticosteroid Revenue Market Share Forecast by Application (2025-2030)
